ghk-cu and retatrutide Switching From Tirzepatide to + My New Peptide Stack (GHK-Cu, Glutathione) Retatrutide - Welcome

GLP-1 therapy treats a chronic metabolic condition, so many patients continue for a year or longer, with periodic review of dose and goals

Some people stopped due to cost, while others stopped a treatment because they hit their weight loss goal or experienced side effects

IV treatments are administered by licensed Registered Nurses - many with years of ER and ICU experience

Monitoring includes periodic HbA1c measurement, weight tracking, assessment for adverse effects, and evaluation of diabetic retinopathy status (particularly with semaglutide)

Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors

Rev Diabetes Stud